Cargando…
Recently Discovered Secondary Metabolites from Streptomyces Species
The Streptomyces genus has been a rich source of bioactive natural products, medicinal chemicals, and novel drug leads for three-quarters of a century. Yet studies suggest that the genus is capable of making some 150,000 more bioactive compounds than all Streptomyces secondary metabolites reported t...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8838263/ https://www.ncbi.nlm.nih.gov/pubmed/35164153 http://dx.doi.org/10.3390/molecules27030887 |
_version_ | 1784650083119136768 |
---|---|
author | Lacey, Heather J. Rutledge, Peter J. |
author_facet | Lacey, Heather J. Rutledge, Peter J. |
author_sort | Lacey, Heather J. |
collection | PubMed |
description | The Streptomyces genus has been a rich source of bioactive natural products, medicinal chemicals, and novel drug leads for three-quarters of a century. Yet studies suggest that the genus is capable of making some 150,000 more bioactive compounds than all Streptomyces secondary metabolites reported to date. Researchers around the world continue to explore this enormous potential using a range of strategies including modification of culture conditions, bioinformatics and genome mining, heterologous expression, and other approaches to cryptic biosynthetic gene cluster activation. Our survey of the recent literature, with a particular focus on the year 2020, brings together more than 70 novel secondary metabolites from Streptomyces species, which are discussed in this review. This diverse array includes cyclic and linear peptides, peptide derivatives, polyketides, terpenoids, polyaromatics, macrocycles, and furans, the isolation, chemical structures, and bioactivity of which are appraised. The discovery of these many different compounds demonstrates the continued potential of Streptomyces as a source of new and interesting natural products and contributes further important pieces to the mostly unfinished puzzle of Earth’s myriad microbes and their multifaceted chemical output. |
format | Online Article Text |
id | pubmed-8838263 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-88382632022-02-13 Recently Discovered Secondary Metabolites from Streptomyces Species Lacey, Heather J. Rutledge, Peter J. Molecules Review The Streptomyces genus has been a rich source of bioactive natural products, medicinal chemicals, and novel drug leads for three-quarters of a century. Yet studies suggest that the genus is capable of making some 150,000 more bioactive compounds than all Streptomyces secondary metabolites reported to date. Researchers around the world continue to explore this enormous potential using a range of strategies including modification of culture conditions, bioinformatics and genome mining, heterologous expression, and other approaches to cryptic biosynthetic gene cluster activation. Our survey of the recent literature, with a particular focus on the year 2020, brings together more than 70 novel secondary metabolites from Streptomyces species, which are discussed in this review. This diverse array includes cyclic and linear peptides, peptide derivatives, polyketides, terpenoids, polyaromatics, macrocycles, and furans, the isolation, chemical structures, and bioactivity of which are appraised. The discovery of these many different compounds demonstrates the continued potential of Streptomyces as a source of new and interesting natural products and contributes further important pieces to the mostly unfinished puzzle of Earth’s myriad microbes and their multifaceted chemical output. MDPI 2022-01-28 /pmc/articles/PMC8838263/ /pubmed/35164153 http://dx.doi.org/10.3390/molecules27030887 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Lacey, Heather J. Rutledge, Peter J. Recently Discovered Secondary Metabolites from Streptomyces Species |
title | Recently Discovered Secondary Metabolites from Streptomyces Species |
title_full | Recently Discovered Secondary Metabolites from Streptomyces Species |
title_fullStr | Recently Discovered Secondary Metabolites from Streptomyces Species |
title_full_unstemmed | Recently Discovered Secondary Metabolites from Streptomyces Species |
title_short | Recently Discovered Secondary Metabolites from Streptomyces Species |
title_sort | recently discovered secondary metabolites from streptomyces species |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8838263/ https://www.ncbi.nlm.nih.gov/pubmed/35164153 http://dx.doi.org/10.3390/molecules27030887 |
work_keys_str_mv | AT laceyheatherj recentlydiscoveredsecondarymetabolitesfromstreptomycesspecies AT rutledgepeterj recentlydiscoveredsecondarymetabolitesfromstreptomycesspecies |